Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ALNY | ALNYLAM PHARMACEUTICALS, INC. | CSO & EVP, Head of Research | $3.41M | -$7M | -67.2% | Nov 25, 2024 |
OVID | Ovid Therapeutics Inc. | Director | Dec 12, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|